Co-expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene

Journal article

Open access

Peer reviewed

S Mineishi, S Nakahara, N Takebe, D Banerjee, S.-C Zhao and J. R Bertino

Gene therapy, Vol.4(6), pp.570-576

1997

PMID: 9231073

Abstract

Biological and medical sciences

Fundamental and applied biological sciences. Psychology

Health. Pharmaceutical industry

Industrial applications and implications. Economical aspects

Biotechnology

Gene Therapy

url

https://doi.org/10.1038/sj.gt.3300439View

Version of Record (VoR) Open

13 Record Views

Title: Co-expression of the herpes simplex virus thymidine kinase gene potentiates methotrexate resistance conferred by transfer of a mutated dihydrofolate reductase gene
Creators: S Mineishi - Program of Molecular Pharmacology and Experimental Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY, United States
S Nakahara - Program of Molecular Pharmacology and Experimental Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY, United States
N Takebe - Program of Molecular Pharmacology and Experimental Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY, United States
D Banerjee - Program of Molecular Pharmacology and Experimental Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY, United States
S.-C Zhao - Program of Molecular Pharmacology and Experimental Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY, United States
J. R Bertino - Program of Molecular Pharmacology and Experimental Therapeutics, Memorial Sloan-Kettering Cancer Center, New York, NY, United States
Publication Details: Gene therapy, Vol.4(6), pp.570-576
Date published: 1997
Publisher: Nature Publishing Group
Academic Unit: Bertino Office; Pharmacology (RWJMS)
Language: English
Resource Type: Journal article
Identifiers: 991031665731404646